Public Reporting Information
ACO Name and Location
Pacific Accountable Care, LLC
Previous Names: N/A
15611 Pomerado Road
Suite 575
Poway, California 92064
ACO Primary Contact
|
Primary Contact Name |
Mary Kay Payne |
|
Primary Contact Phone Number |
844-544-4054 |
|
Primary Contact Email Address |
admin@pacificaccountablecare.com |
Organizational Information
ACO Participants:
|
ACO Participants |
ACO Participant in Joint Venture (Enter Y or N) |
|||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N | |||
|
N N |
ACO Governing Body:
|
Member |
Member's Voting Power - Expressed as a percentage or number |
Membership Type |
ACO Participant Legal Business Name/DBA, if Applicable |
||
|
Last Name |
First Name |
Title/Position |
|||
|
Balikian, M.D. |
Philip |
Manager |
1 |
ACO Participant Representative |
Arch Health Partners |
|
Hansen |
Diane |
Manager |
1 |
ACO Participant Representative |
Palomar Health |
|
Wells, M.D. |
Todd |
Manager |
1 |
ACO Participant Representative |
Arch Health Partners |
| Maletz, M.D. | Louis | Manager | 1 | ACO Participant Representative | Arch Health Partners |
|
Rivera, M.D. |
Marcelo | Manager | 1 | ACO Participant Representative | Marcelo Rivera |
|
Shephard, R.N. |
Rena | Manager | 1 | Medicare Beneficiary Representative | N/A |
|
Panicker, M.D. |
Cibu |
Manager |
1 |
ACO Participant Representative |
Vista Community Clinic |
| Curran, M.D. | Perrin | Manager | 1 | ACO Participant Representative | Perrin Curran |
| Paz, M.D. | Alejandro | Manager | 1 | ACO Participant Representative | Graybill Medical Group Inc. |
| Rodriguez, M.D. | George | Manager | 1 | ACO Participant Representative | Graybill Medical Group Inc. |
Key ACO Clinical and Administrative Leadership:
|
Mary Kay Payne |
ACO Executive |
|
Louis Maletz, MD |
Medical Director |
|
Dianne St. John |
Compliance Officer |
| Fritz Steen, RN | Quality Assurance/Improvement Officer |
Associated Committees and Committee Leadership:
|
Committee Name |
Committee Leader Name and Position |
|---|---|
|
Nominations Committee |
Belinda Dure-Smith, M.D. |
| Quality Committee | Louis Maletz, M.D. |
| Finance Committee | Vacant |
| Network Development Committee | Louis Maletz, M.D. |
| Education and Training Committee | Jason Black, M.D. |
Types of ACO participants, or Combinations of Participants, that Formed the ACO:
- Partnerships or joint venture arrangements between hospitals and ACO professionals
- Networks of individual practices of ACO professionals
Shared Savings and Losses
Amount of Shared Savings/Losses
- Second Agreement Period
- Performance Year 2020, $ 2,721,004.10
- First Agreement Period
- Performance Year 2019, $ 0
- Performance Year 2018, $ 0
- Performance Year 2017, $ 2,630,942
-
Shared Savings Distribution:
- Second Agreement Period
- Performance Year 2020
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 15%
- Proportion of distribution to ACO participants: 35%
- Performance Year 2020
- First Agreement Period
- Performance Year 2019
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2018
- Proportion invested in infrastructure: N/A
- Proportion invested in redesigned care processes/resources: N/A
- Proportion of distribution to ACO participants: N/A
- Performance Year 2017
- Proportion invested in infrastructure: 50%
- Proportion invested in redesigned care processes/resources: 15%
- Proportion of distribution to ACO participants: 35%
- Performance Year 2019
Quality Performance Results
2020 Quality Performance Results:
|
ACO # |
Measure Name |
Rate |
ACO Mean |
|
ACO-13 |
Falls: Screening for Future Fall Risk |
45.75 |
84.97 |
|
ACO-14 |
Preventive Care and Screening Influenza Immunization |
52.64 |
76.03 |
|
ACO-17 |
Preventive Care and Screening: Tobacco Use: Screening and Cessation Intervention |
51.35 |
81.67 |
|
ACO-18 |
Preventive Care and Screening: Screening for Depression and Follow-up Plan |
33.27 |
71.46 |
|
ACO-19 |
Colorectal Cancer Screening |
36.33 |
72.59 |
|
ACO-20 |
Breast Cancer Screening |
38.16 |
74.05 |
|
ACO-27 |
Diabetes Mellitus: Hemoglobin A1c Poor Control |
35.80 |
14.70 |
|
ACO-28 |
Hypertension (HTN): Controlling High Blood Pressure |
62.13 |
72.87 |
|
ACO-42 |
Statin Therapy for the Prevention and Treatment of Cardiovascular Disease |
84.09 |
83.37 |
|
ACO-43 |
Ambulatory Sensitive Condition Acute Composite (AHRQ*Prevention Quality Indicators (PQI#91)) |
0.65 |
0.95 |
Due to COVID-19 Pandemic, ACO-9 and ACO-38 have reverted to pay-for-reporting measures for
Performance.
Please note, the ACO-40 Depression Remission at 12 months quality measure is not included in public
reporting due to low sample size. The Centers for Medicare & Medicaid Services (CMS) also
waived the requirement for ACOs to field a CAHPS for ACOs survey for PY 2020 through the Physician
Fee Schedule Final Rule for Calendar Year 2021. Additionally, CMS reverted ACO-8 Risk-Standardized,
All Condition Readmission and ACO-38 Risk-Standardized Acute Admission Rates for Patients with
Multiple Chronic Conditions to pay-for-reporting, given the impact of the coronavirus disease 2019
(COVID-19) public health emergency (PHE) on these measures.”
“
For Previous Years’ Financial and Quality Performance Results, please visit data.cms.gov
Print 